LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Apatinib plus vinorelbine: A novel combination of all-oral regimen in heavily pretreated patients with metastatic HER2-negative breast cancer.

Photo by nci from unsplash

e13096Background: Antiangiogenic therapy in combination with chemotherapy is effective in control advanced breast cancer. Apatinib is an oral highly potent tyrosine kinase inhibitor targeting vascu... Click to show full abstract

e13096Background: Antiangiogenic therapy in combination with chemotherapy is effective in control advanced breast cancer. Apatinib is an oral highly potent tyrosine kinase inhibitor targeting vascu...

Keywords: combination; apatinib plus; cancer apatinib; breast cancer

Journal Title: Journal of Clinical Oncology
Year Published: 2018

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.